North America Antibiotics Market
The North America Antibiotics Market size was valued at US$ 13,527.79 Mn in 2019 and is projected to reach US$ 18,004.25 Mn by 2027, growing at a CAGR of 3.9% during 2020 - 2027.
Report Coverage
- Drug Class: Sulfonamides, Aminoglycosides, Carbapenem, Macrolides, Fluoroquinolones, Penicillin, Cephalosporin
- Action Mechanism: Mycolic Acid Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors
US$ 13,527.79 Mn
Market size in 2019
US$ 18,004.25 Mn
Market Size by 2027
3.9%
CAGR, 2020 - 2027
2020-2027
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Antibiotics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Antibiotics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Antibiotics Market Regional Analysis
6.2 North America Antibiotics Market Revenue 2017-2027 (US$ Million)
6.3 North America Antibiotics Market Forecast Analysis
7. North America Antibiotics Market Analysis – by Drug Class
7.1 Sulfonamides
- 7.1.1 Overview
- 7.1.2 Sulfonamides: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Aminoglycosides
- 7.2.1 Overview
- 7.2.2 Aminoglycosides: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Carbapenem
- 7.3.1 Overview
- 7.3.2 Carbapenem: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Macrolides
- 7.4.1 Overview
- 7.4.2 Macrolides: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Fluoroquinolones
- 7.5.1 Overview
- 7.5.2 Fluoroquinolones: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 Penicillin
- 7.6.1 Overview
- 7.6.2 Penicillin: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.7 Cephalosporin
- 7.7.1 Overview
- 7.7.2 Cephalosporin: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Antibiotics Market Analysis – by Action Mechanism
8.1 Mycolic Acid Inhibitors
- 8.1.1 Overview
- 8.1.2 Mycolic Acid Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 RNA Synthesis Inhibitors
- 8.2.1 Overview
- 8.2.2 RNA Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 DNA Synthesis Inhibitors
- 8.3.1 Overview
- 8.3.2 DNA Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Protein Synthesis Inhibitors
- 8.4.1 Overview
- 8.4.2 Protein Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Cell Wall Synthesis Inhibitors
- 8.5.1 Overview
- 8.5.2 Cell Wall Synthesis Inhibitors: North America Antibiotics Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Antibiotics Market – North America Analysis
9.1 Overview
9.2 North America- 9.2.1 North America Antibiotics Market Breakdown, by Key Country, 2020 and 2027 (%)
- 9.2.1.1 North America Antibiotics Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 US: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 US: North America Antibiotics Market Breakdown, by Drug Class
- 9.2.1.1.2 US: North America Antibiotics Market Breakdown, by Action Mechanism
- 9.2.1.2 Canada: North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Canada: North America Antibiotics Market Breakdown, by Drug Class
- 9.2.1.2.2 Canada: North America Antibiotics Market Breakdown, by Action Mechanism
- 9.2.1.3 Mexico : North America Antibiotics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Mexico : North America Antibiotics Market Breakdown, by Drug Class
- 9.2.1.3.2 Mexico : North America Antibiotics Market Breakdown, by Action Mechanism
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Johnson & Johnson Services, Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bristol-Myers Squibb Company
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Eli Lilly and Company.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Abbott
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Pfizer Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
